The clinical trials below are available in the specialty you selected. Choose a different specialty.
Carbohydrate and Prostate Study 2 (CAPS2)
The purpose of this study is to examine the effects of dietary interventions on prostate cancer treatment.
(REF# 00041857)
CAPS1 Carbohydrate and Prostate Cancer Study
The purpose of this study is to examine the effects of dietary interventions on prostate cancer treatment.
(REF# 00010519)
TAK-700 in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (CRPC) and a Rising Prostate-Specific Antigen (PSA)
This study is an open-label, multicenter, phase II study of TAK-700 in patients with nonmetastatic CRPC and rising PSA.
(REF# 20429)
Prostate Cancer Recovery Enhancement for African American Men and Their Intimate Partners
The PROCARE study is a telephone based clinical trial that will evaluate two educational interventions tailored for African American prostate cancer survivors and their intimate partners.
(REF# 3525)
A Prospective Randomized Phase III Translational NIH Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
This study seeks adult cancer patients to determine if a daily injection of a blood-thinner, dalteparin, for three months can safely and effectively reduce the frequency of blood clots in patients at increased risk.
(REF# 11739)
